Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Ceballos, P.

Refine Results

Resource Type

Availability

Faculty

Collection

Author

Language

Search results

  • RSS Feed
(1 - 2 of 2)
Daratumumab after allogeneic hematopoietic cell transplantation for multiple myeloma is safe and synergies with pre-existing chronic graft versus host disease. A retrospective study from the CMWP EBMT
Vincent, L.; Gras, L.; Ceballos, P.; Finke, J.; Passweg, J.; Harel, S.; ... ; Beksac, M. 2022
Daratumumab after allogeneic hematopoietic cell transplantation for multiple myeloma is safe and synergies with pre-existing chronic graft versus host disease. A retrospective study from the CMWP EBMT
Article / Letter to editor
metadata only
Salvage use of allogeneic HSCT after reduced intensity conditioning from unrelated donors in multiple myeloma: outcomes from 10/10 HLA-matched unrelated donors, 9/10 HLA-mismatched unrelated donors and cord blood. A study by the EBMT and Eurocord
Michallet, M.; Sobh, M.; Dubois, V.; Iacobelli, S.; Koster, L.; Biezen, A. van; ... ; EBMT Chronic Malignancies Working 2016
Salvage use of allogeneic HSCT after reduced intensity conditioning from unrelated donors in multiple myeloma: outcomes from 10/10 HLA-matched unrelated donors, 9/10 HLA-mismatched unrelated donors and cord blood. A study by the EBMT and Eurocord
Article / Letter to editor
metadata only